SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-142027 from Harpoon Therapeutics, Inc. (CIK 0001708493)

Harpoon Therapeutics, Inc. (CIK 0001708493)
Date: May 11, 2023 · CIK: 0001708493 · Accession: 0001193125-23-142027

AI Filing Summary & Sentiment

File numbers found in text: 333-271400

Date
May 11, 2023
Author
Not clearly detected
Form
CORRESP
Company
Harpoon Therapeutics, Inc. (CIK 0001708493)

Letter

Re: Harpoon Therapeutics, Inc.

May 11, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Ms. Cindy Polynice

Registration Statement on Form S-3, as amended

File No. 333-271400

Acceleration Request

Requested Date: May 15,

Requested Time: 4:00 PM Eastern Daylight Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3, as amended (File No. 333-271400) (the “Registration Statement”) to become effective on Monday, May 15, 2023 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Marina Remennik at (650) 843-5124.

Very truly yours,
HARPOON THERAPEUTICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 May 11, 2023

VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

Washington, D.C. 20549

 Attn: Ms. Cindy Polynice

Re: Harpoon Therapeutics, Inc.

 Registration
Statement on Form S-3, as amended

 File No. 333-271400

Acceleration Request

 Requested Date: May 15,
2023

 Requested Time: 4:00 PM Eastern Daylight Time

Ladies and Gentlemen:

 In accordance with Rule 461 under the
Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the
Registration Statement on Form S-3, as amended (File No. 333-271400) (the “Registration Statement”) to become effective on Monday,
May 15, 2023 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The
Registrant hereby authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the
Registrant, at (312) 881-6680, or in her absence, Marina Remennik at (650) 843-5124.

Very truly yours,

HARPOON THERAPEUTICS, INC.

By:

 /s/ Julie Eastland

Julie Eastland

President and Chief Executive Officer

cc:
 Courtney M.W. Tygesson, Cooley LLP

Marina Remennik, Cooley LLP